MARKET

SGHT

SGHT

Sight Sciences, Inc.
NASDAQ
8.14
+0.14
+1.69%
After Hours: 8.14 0 0.00% 16:10 09/11 EDT
OPEN
8.13
PREV CLOSE
8.01
HIGH
8.32
LOW
7.99
VOLUME
179.56K
TURNOVER
--
52 WEEK HIGH
9.24
52 WEEK LOW
3.190
MARKET CAP
448.42M
P/E (TTM)
-14.6245
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SGHT last week (0831-0904)?
Weekly Report · 4d ago
Weekly Report: what happened at SGHT last week (0824-0828)?
Weekly Report · 08/31 10:31
Weekly Report: what happened at SGHT last week (0817-0821)?
Weekly Report · 08/24 10:31
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Moderna (MRNA), Merck & Company (MRK) and Sight Sciences (SGHT)
TipRanks · 08/19 13:30
Sight Sciences' TearCare Becomes First FDA-Approved MGD Therapy For Dry Eye Disease; Stock Up
NASDAQ · 08/19 12:29
Sight Sciences Announces FDA Label Expansion For TearCare Dry Eye Therapy
NASDAQ · 08/19 11:50
Sight Sciences announces updated TearCare System Indications for Use
TipRanks · 08/19 11:35
Sight Sciences Announces Updated FDA Indications For TearCare, Effective August 18
Benzinga · 08/19 11:10
More
About SGHT
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.

Webull offers Sight Sciences Inc stock information, including NASDAQ: SGHT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGHT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGHT stock methods without spending real money on the virtual paper trading platform.